6B1 was able to bind tumor cell lines CML/ALL BV173, AML SET-2, mantle cell lymphoma Jeko, and ovarian cancer SKOV-3 (Figure 2, A–E). This evidence concerns the gene SETD2 and acute myeloid leukemia.